A new approach to resistant prostate cancer by Angus Liu Thursday, August 29, 2019 Blocking the enzyme CDK7 could be a new way to overcome resistant prostate cancer, and one drug is already in trials.
Carrick hires ex-Tesaro CFO, shifts focus toward U.S. by Nick Paul Taylor Friday, June 28, 2019 The Anglo-Irish cancer biotech has appointed ex-Tesaro CFO Tim Pearson to lead the company from its new site in Boston.
